{"Pargyline":{"Synonym":["Benzyl-methyl-2-propinylamin","Methylbenzylpropynylamine","Methylbenzylpropynylamine hydrochloride","N-Benzyl-N-methyl-2-propyn-1-amine","N-Benzyl-N-methyl-2-propynylamine","N-Benzyl-N-methyl-2-propynylamine hydrochloride","N-Methyl-N-2-propynylbenzylamine","Paragyline","Pargylamine","Pargylin","Pargyline chloride","Pargyline hydrochloride","Eudatin","Eutonyl","Eutonyl-ten","Lopac-P-8013"],"SuperCategory":"Molecular entity","Comment":"taken from DrugBank","Id":"DB01626","Curator":"ab","Has role":"Drug","DefiningCitation":"http:\/\/www.drugbank.ca\/drugs\/DB01626","Definition":"A monoamine oxidase inhibitor with antihypertensive properties. (PubChem) Pharmacology: Pargyline is a monoamine oxidase B (MAO-B) inhibitor with antihypertensive properties. Patients taking pargyline must avoid concurrent consumption of tyramine-containing foods such as bleu cheese and beer, as this can lead to a hypertensive crisis. Mechanism of action: Pargyline functions by inhibiting the metabolism of catecholamines and tyramine within presynaptic nerve terminals. Drug type: Approved. Small Molecule. Drug category: Antihypertensive Agents. Monoamine Oxidase Inhibitors"}}